# Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer

> **NCT01400438** · NA · COMPLETED · sponsor: **Centre Francois Baclesse** · enrollment: 70 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** questionnaires
- **OTHER:** questionnaires

## Key facts

- **NCT ID:** NCT01400438
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-05
- **Final completion:** 2015-09
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400438, "Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01400438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*